Docebo Inc. filings document the regulatory disclosures of a Canadian operating company listed on Nasdaq and the Toronto Stock Exchange. Its Form 6-K reports include IFRS interim financial statements, management discussion and analysis, earnings releases, Canadian executive certifications and XBRL exhibits tied to operating and financial results.
The filing record also covers annual general meeting materials, management information circulars, proxy solicitation and shareholder voting matters. Other disclosures address investor presentations, registration statement incorporation by reference, material-event reports, capital-structure matters and common-share repurchase activity, including substantial issuer bid documentation and related governance information.
Intercap Inc., Intercap Equity Inc., and Jason Chapnik report a controlling stake in Docebo Inc. through a Schedule 13D filing. They beneficially own 16,318,371 common shares, representing 56.7% of Docebo’s 28,757,629 common shares outstanding as of February 1, 2026. A share purchase agreement dated November 27, 2025 provides for Intercap to acquire 3,630,715 shares from WPGG 14 Investment Ltd. IV at $18.77 per share, for a total of $68,148,520.55, with closing expected on or about February 27, 2026, subject to customary conditions. An investor rights agreement grants Intercap-related entities significant board nomination, registration and pre‑emptive rights, and following completion of the purchase they will be entitled to nominate a majority of Docebo’s directors.
Docebo Inc. has formally commenced a substantial issuer bid to repurchase for cancellation up to 2,941,176 of its outstanding common shares. The company is offering US$20.40 per share, with the total amount of shares bought back capped at an aggregate price of up to US$60,000,000.
The offer begins on February 3, 2026 and is scheduled to expire on March 10, 2026, unless it is extended, varied or withdrawn. Full details are provided in the offer documents filed on SEDAR+ and EDGAR, which have been mailed to shareholders. Docebo emphasizes that investors should carefully review these documents before deciding whether to tender shares.
Docebo Inc. has launched a substantial issuer bid to repurchase for cancellation up to US$60,000,000 of its common shares at US$20.40 per share, representing approximately 10.23% of its issued and outstanding shares on a non‑diluted basis.
The company plans to fund the offer with about US$30,000,000 of cash on hand and an approximately US$30,000,000 draw on its credit facility, which it is seeking to increase from US$50,000,000 to US$100,000,000, subject to lender approval. Majority shareholder Intercap Equity Inc., which holds about 56.6% of the shares, does not intend to participate. Docebo has also released preliminary, unaudited fourth quarter 2025 results and provided financial guidance for 2026, and has suspended repurchases under its normal course issuer bid while the offer is outstanding.
Docebo Inc. filed a Form 6-K as a foreign private issuer to furnish its latest interim information to U.S. investors. The report packages unaudited condensed consolidated interim financial statements and management’s discussion and analysis for the three and nine months ended September 30, 2025, giving a detailed view of the company’s third-quarter 2025 performance and financial condition.
The filing also includes a press release titled “Docebo Reports Third Quarter 2025 Results,” CEO and CFO interim filing certificates under Canadian regulations, and full Inline XBRL data files for electronic analysis. Together, these materials provide a comprehensive update on Docebo’s Q3 2025 operations, governance sign-offs, and structured financial disclosures.
Docebo Inc. submitted a Form 6-K as a foreign private issuer, mainly to furnish its second-quarter 2025 reporting package. The filing includes unaudited condensed consolidated interim financial statements and management’s discussion and analysis for the three and six months ended June 30, 2025.
It also attaches a press release dated August 8, 2025 titled “Docebo Reports Second Quarter 2025 Results,” CEO and CFO interim filing certificates required under Canadian regulations, and full Inline XBRL data files, providing structured financial information for electronic analysis.